메뉴 건너뛰기




Volumn 15, Issue 3-4, 1998, Pages 173-186

Regulatory aspects of the formulation and evaluation of L-thyroxene tablets

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; SYNTHYROID; UNCLASSIFIED DRUG;

EID: 0031740629     PISSN: 10601333     EISSN: None     Source Type: Journal    
DOI: 10.3109/10601339809109194     Document Type: Article
Times cited : (10)

References (17)
  • 1
    • 0013069775 scopus 로고    scopus 로고
    • Thursday, 14 August
    • Federal Register, Volume 62, No. 157, Thursday, 14 August, 1997 43535-43538.
    • (1997) Federal Register , vol.62 , Issue.157 , pp. 43535-43538
  • 3
    • 84943211433 scopus 로고
    • E. Kendall, J.A.M.A. 64, 2042-2043 (1915).
    • (1915) J.A.M.A. , vol.64 , pp. 2042-2043
    • Kendall, E.1
  • 11
    • 0001643856 scopus 로고    scopus 로고
    • D. Rennie, J.A.M.A. 277, 1238-1243 (1997).
    • (1997) J.A.M.A. , vol.277 , pp. 1238-1243
    • Rennie, D.1
  • 14
    • 7844245569 scopus 로고    scopus 로고
    • 97N-0314/CP2, Citizens Petition filed 15 December, 1997 to FDA
    • 97N-0314/CP2, Citizens Petition filed 15 December, 1997 to FDA.
  • 15
    • 7844234878 scopus 로고    scopus 로고
    • 97N-0314/CP1, Citizens Petition filed 15 October, 1997 to FDA
    • 97N-0314/CP1, Citizens Petition filed 15 October, 1997 to FDA.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.